Shares of Atossa jumped 10% before regular trading hours, tied to the announcement of Orphan Drug Designation. This special status, granted to products for rare diseases, often provides key competitive benefits and regulatory incentives.

In a significant reversal, British Columbia will resume funding for Brineura, the vital drug treatment for 10-year-old Langford resident Charleigh Pollock, who battles a rare terminal disease. Health Minister Josie Osborne personally informed the family of the decision, offering renewed hope for Charleigh’s ongoing care.